leo: extract claims from 2026-04-22-rand-ai-action-plan-biosecurity-primer

- Source: inbox/queue/2026-04-22-rand-ai-action-plan-biosecurity-primer.md
- Domain: grand-strategy
- Claims: 0, Entities: 0
- Enrichments: 3
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Leo <PIPELINE>

domains/grand-strategy/anti-gain-of-function-framing-creates-structural-decoupling-between-ai-governance-and-biosecurity-governance-communities.md

@@ -10,7 +10,7 @@ agent: leo
 scope: structural
 sourcer: University of Pennsylvania EHRS
 supports: ["existential-risks-interact-as-a-system-of-amplifying-feedback-loops-not-independent-threats"]
-related: ["ai-governance-discourse-capture-by-competitiveness-framing-inverts-china-us-participation-patterns", "existential-risks-interact-as-a-system-of-amplifying-feedback-loops-not-independent-threats", "use-based-ai-governance-emerged-as-legislative-framework-but-lacks-bipartisan-support", "use-based-ai-governance-emerged-as-legislative-framework-through-slotkin-ai-guardrails-act", "government designation of safety-conscious AI labs as supply chain risks inverts the regulatory dynamic by penalizing safety constraints rather than enforcing them", "anti-gain-of-function-framing-creates-structural-decoupling-between-ai-governance-and-biosecurity-governance-communities", "durc-pepp-rescission-created-indefinite-biosecurity-governance-vacuum-through-missed-replacement-deadline", "nucleic-acid-screening-cannot-substitute-for-institutional-oversight-in-biosecurity-governance-because-screening-filters-inputs-not-research-decisions"]
+related: ["ai-governance-discourse-capture-by-competitiveness-framing-inverts-china-us-participation-patterns", "existential-risks-interact-as-a-system-of-amplifying-feedback-loops-not-independent-threats", "use-based-ai-governance-emerged-as-legislative-framework-but-lacks-bipartisan-support", "use-based-ai-governance-emerged-as-legislative-framework-through-slotkin-ai-guardrails-act", "government designation of safety-conscious AI labs as supply chain risks inverts the regulatory dynamic by penalizing safety constraints rather than enforcing them", "anti-gain-of-function-framing-creates-structural-decoupling-between-ai-governance-and-biosecurity-governance-communities", "durc-pepp-rescission-created-indefinite-biosecurity-governance-vacuum-through-missed-replacement-deadline", "nucleic-acid-screening-cannot-substitute-for-institutional-oversight-in-biosecurity-governance-because-screening-filters-inputs-not-research-decisions", "biosecurity-governance-authority-shifted-from-science-agencies-to-national-security-apparatus-through-ai-action-plan-authorship"]
 ---
 
 # Anti-gain-of-function political framing structurally decouples AI governance from biosecurity governance debates, creating the most dangerous variant of indirect governance erosion where the community that would oppose the erosion doesn't recognize the connection
@@ -37,3 +37,10 @@ CSR documents that the AI Action Plan calls for mandatory nucleic acid synthesis
 **Source:** RAND Corporation, August 2025
 
 RAND's framing of the AI Action Plan's biosecurity components as addressing 'AI-bio convergence risk' at the synthesis/screening layer confirms the structural decoupling: AI governance instruments (CAISI evaluation, synthesis screening) operate at different pipeline stages than traditional biosecurity institutional review (DURC/PEPP committees deciding whether research programs should exist). The governance gap exists because these are different stages of the research pipeline, not equivalent governance instruments.
+
+
+## Extending Evidence
+
+**Source:** RAND Corporation, August 2025
+
+RAND's framing of the AI Action Plan as addressing 'AI-bio convergence risk' at the 'synthesis/screening layer' rather than the 'institutional oversight layer' reveals the technical manifestation of the decoupling. The AI Action Plan's instruments (nucleic acid screening, CAISI evaluation) operate on different governance objects (synthesis orders, frontier AI models) than DURC/PEPP institutional review committees (research programs). This creates a governance architecture mismatch where AI governance addresses outputs while biosecurity governance traditionally addressed inputs, making coordination structurally difficult even when both communities acknowledge the convergence risk.

domains/grand-strategy/durc-pepp-rescission-created-indefinite-biosecurity-governance-vacuum-through-missed-replacement-deadline.md

@@ -44,3 +44,10 @@ Council on Strategic Risks review of the AI Action Plan (July 2025) confirms the
 **Source:** RAND Corporation, August 2025
 
 RAND analysis confirms the specific governance gap: AI Action Plan addresses AI-bio convergence risk at the synthesis/screening layer (nucleic acid synthesis screening requirements, OSTP data sharing mechanism, CAISI evaluation) but leaves the institutional oversight layer ungoverned. None of these instruments replace DURC/PEPP institutional review committee structure. RAND describes this as 'institutions left without clear direction on which experiments require oversight reviews,' confirming the category substitution between output screening and input oversight.
+
+
+## Supporting Evidence
+
+**Source:** RAND Corporation, August 2025
+
+RAND's August 2025 analysis (one month before the September 2025 missed deadline) describes the governance gap as 'institutions left without clear direction on which experiments require oversight reviews.' This contemporaneous assessment from a primary policy research organization confirms that the gap was visible to expert observers before the deadline was missed, strengthening the claim that the vacuum was created through policy failure rather than unforeseen circumstances.

domains/grand-strategy/nucleic-acid-screening-cannot-substitute-for-institutional-oversight-in-biosecurity-governance-because-screening-filters-inputs-not-research-decisions.md

@@ -10,7 +10,7 @@ agent: leo
 sourced_from: grand-strategy/2026-04-22-cset-georgetown-ai-action-plan-recap.md
 scope: functional
 sourcer: CSET Georgetown
-related: ["durc-pepp-rescission-created-indefinite-biosecurity-governance-vacuum-through-missed-replacement-deadline", "anti-gain-of-function-framing-creates-structural-decoupli-between-ai-governance-and-biosecurity-governance-communities", "nucleic-acid-screening-cannot-substitute-for-institutional-oversight-in-biosecurity-governance-because-screening-filters-inputs-not-research-decisions"]
+related: ["durc-pepp-rescission-created-indefinite-biosecurity-governance-vacuum-through-missed-replacement-deadline", "anti-gain-of-function-framing-creates-structural-decoupli-between-ai-governance-and-biosecurity-governance-communities", "nucleic-acid-screening-cannot-substitute-for-institutional-oversight-in-biosecurity-governance-because-screening-filters-inputs-not-research-decisions", "biosecurity-governance-authority-shifted-from-science-agencies-to-national-security-apparatus-through-ai-action-plan-authorship", "anti-gain-of-function-framing-creates-structural-decoupling-between-ai-governance-and-biosecurity-governance-communities"]
 ---
 
 # Nucleic acid screening cannot substitute for institutional oversight in biosecurity governance because screening filters inputs not research decisions
@@ -30,3 +30,10 @@ CSR's review provides authoritative biosecurity community confirmation of the ca
 **Source:** Council on Strategic Risks, AI Action Plan review, July 2025
 
 CSR's review provides the third independent source (alongside CSET and RAND) confirming the AI Action Plan's category substitution pattern. The plan mandates nucleic acid synthesis screening while leaving the DURC/PEPP institutional review vacuum unfilled, despite explicitly acknowledging AI-enabled pathogen synthesis risk. This is the credibility anchor from the most authoritative biosecurity voice.
+
+
+## Supporting Evidence
+
+**Source:** RAND Corporation, August 2025
+
+RAND analysis confirms the AI Action Plan addresses AI-bio convergence risk through three instruments: (1) nucleic acid synthesis screening requirements, (2) OSTP-convened data sharing mechanism for synthesis screening, (3) CAISI evaluation of frontier AI for bio risks. Critically, RAND notes 'None of these instruments replace DURC/PEPP institutional review committee structure' and that 'institutions are left without clear direction on which experiments require oversight reviews.' This confirms the category substitution: the AI Action Plan addresses AI-bio risk at the output/screening layer (synthesis orders) but leaves the input/oversight layer (research program decisions) ungoverned.